Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
OPTIFAST
Description:
A commercial, medically supervised weight-management program using low-calorie meal replacements and clinical support to treat obesity.
Related topics:
Bariatric Surgery and Outcomes (15%),
Pharmacology and Obesity Treatment (13%),
Diabetes, Cardiovascular Risks, and Lipoproteins (8%),
Dietary Effects on Health (8%)
OpenAlex ID:
keywords/optifast
Systematic Review: An Evaluation of Major Commercial Weight Loss Programs in the United States
2005
·
Adam Gilden Tsai
, Thomas A. Wadden
·
Annals of Internal Medicine
·
891
Change in Liver Size and Fat Content after Treatment with Optifast® Very Low Calorie Diet
2006
·
Mark Lewis
, Madeleine Phillips
, et al.
·
Obesity Surgery
·
262
A Diet and Exercise Program to Improve Clinical Outcomes in Patients with Obstructive Sleep Apnea – A Feasibility Study
2009
·
Maree Barnes
, Unna Raquel Goldsworthy
, et al.
·
Journal of Clinical Sleep Medicine
·
126
Effectiveness of a Total Meal Replacement Program (OPTIFAST Program) on Weight Loss: Results from the OPTIWIN Study
2018
·
Jamy D. Ard
, Kristina H. Lewis
, et al.
·
Obesity
·
122
PDF
An eight-year experience with a very-low-calorie formula diet for control of major obesity.
1988
·
M A Kirschner
, G Schneider
, et al.
·
PubMed
·
73
Very-low-calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and l-dopa in obesity
1990
·
Katsuaki Tanaka
, Shuji Inoue
, et al.
·
Metabolism
·
54
Leptin, insulin and TNF-α in weight loss
2001
·
C. Xenachis
, E. Samojlik
, et al.
·
Journal of Endocrinological Investigation
·
52
Examination of pretreatment predictors of attrition in a VLCD and behavior therapy weight-loss program
1993
·
Ellen M. Yass-Reed
, Norman J. Barry
, et al.
·
Addictive Behaviors
·
52
Treatment with Optifast reduces hepatic steatosis and increases candidacy rates for living donor liver transplantation
2016
·
Adam Doyle
, Oyedele Adeyi
, et al.
·
Liver Transplantation
·
49
PDF
Weight loss outcome and health benefits associated with the Optifast program in the treatment of obesity.
1989
·
B S Kanders
, G L Blackburn
, et al.
·
PubMed
·
41
A study on the genetics of obesity: Influence of polymorphisms of the beta-3-adrenergic receptor and insulin receptor substrate 1 in relation to weight loss, waist to hip ratio and frequencies of common cardiovascular risk factors
2000
·
H. Benecke
, H. Topak
, et al.
·
Experimental and Clinical Endocrinology & Diabetes
·
39
Inhibitory Control and Hedonic Response towards Food Interactively Predict Success in a Weight Loss Programme for Adults with Obesity
2016
·
Timo Brockmeyer
, Maria Hamze Sinno
, et al.
·
Obesity Facts
·
36
PDF
Exercise training and severe caloric restriction: Effect on lean body mass in the obese
1995
·
Brian C. Leutholtz
, Randall E. Keyser
, et al.
·
Archives of Physical Medicine and Rehabilitation
·
33
Commercial Weight Loss Programs in the Management of Obesity: an Update
2021
·
Marci Laudenslager
, Zoobia W. Chaudhry
, et al.
·
Current Obesity Reports
·
31
Increased saliva cotinine concentrations in smokers during rapid weight loss.
1992
·
Raymond Niaura
, Matthew M. Clark
, et al.
·
Journal of Consulting and Clinical Psychology
·
23
A systematic review of commercial weight loss programmes’ effect on glycemic outcomes among overweight and obese adults with and without type 2 diabetes mellitus
2016
·
Z. W. Chaudhry
, R. S. Doshi
, et al.
·
Obesity Reviews
·
18
Usefulness of mazindol in combined diet therapy consisting of a low-calorie diet and Optifast in severely obese women.
1994
·
T Yoshida
, N Sakane
, et al.
·
PubMed
·
18
Essential amino acid enriched meal replacement improves body composition and physical function in obese older adults: A randomized controlled trial
2022
·
Melynda S. Coker
, Zeinab Barati
, et al.
·
Clinical Nutrition ESPEN
·
16
The OPTIFAST total and partial meal replacement programme reduces cardiometabolic risk in adults with obesity: Secondary and exploratory analysis of the OPTIWIN study
2023
·
Jamy D. Ard
, Ian J. Neeland
, et al.
·
Diabetes Obesity and Metabolism
·
13
PDF
A health economic model to assess the cost-effectiveness of OPTIFAST for the treatment of obesity in the United States
2018
·
Mark Nuijten
, Agnieszka Marczewska
, et al.
·
Journal of Medical Economics
·
13
PDF
Modified fasting in treatment of obesity: Effects on serum lipids, electrolytes, liver enzymes, and blood pressure
1986
·
Lubomir J. Valenta
, Alan N. Elias
·
Postgraduate Medicine
·
13
Efficacy and Safety of Intragastric Balloon Therapy Compared to a Multidisciplinary Weight Loss Program (OPTIFAST) in a Real-World Population: A Propensity Score Matching Analysis
2022
·
Miriam Oster
, Nathalena Hein
, et al.
·
Obesity Facts
·
11
PDF
Meal replacements as a strategy for weight loss in obese hemodialysis patients
2016
·
Annie‐Claude M. Lassemillante
, Veronica Oliver
, et al.
·
Hemodialysis International
·
11
Health-Related Quality of Life in Weight Loss Interventions: Results from the OPTIWIN Trial
2021
·
Livia Dainelli
, Dan Roberto Luo
, et al.
·
International Journal of Environmental Research and Public Health
·
10
PDF
Differences in treatment response to a total diet replacement intervention versus a food‐based intervention: A secondary analysis of the OPTIWIN trial
2020
·
Jamy D. Ard
, Kristina H. Lewis
, et al.
·
Obesity Science & Practice
·
10
PDF
Show more works
View as search
Works count:
101
Citation count:
2,080
Year
Topic
Type